Number of the records: 1
syndróm serotonínový
SYS d020230 LBL 00000cz--a2200000n--4500 005 20250606212932.5 008 980611|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a C25.100.875 066 $a 01 $c 03 150 $a syndróm serotonínový $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a syndróm sérotonínový $2 slo 550 $7 sllk_us_auth*d012701 $Y Serotonin $w b $a serotonín 550 $7 sllk_us_auth*d008996 $Y Monoamine Oxidase Inhibitors $w p $a inhibítory monoaminooxidázy 550 $7 sllk_us_auth*d012701 $Y Serotonin $w p $a serotonín 550 $7 sllk_us_auth*d017367 $Y Selective Serotonin Reuptake Inhibitors $w p $a inhibítory spätného vychytávania serotonínu, selektívne 665 $a 1999 $2 eng 665 $a Serotonin (1980-1992) $2 eng 665 $a Serotonin Uptake Inhibitors/adverse effects (1993-1998) $2 eng 680 9-
$i An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor. $2 eng 750 -2
$a Serotonin Syndrome $2 eng 980 $x M
Number of the records: 1